^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CART-138

i
Other names: CART-138, Anti-CD138-CAR retroviral vector-transduced autologous or donor-derived T cell therapy , Chimeric antigen receptor T cells with specificity for CD138 genetically modified lymphocyte therapy
Associations
News
Company:
Chinese PLA General Hospital
Drug class:
CD138-targeted CAR-T immunotherapy
Associations
News